Literature DB >> 4604857

Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.

A Forsgren, P G Quie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4604857      PMCID： PMC1423361     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  18 in total

1.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  Significance of protein a production by staphylococci.

Authors:  A Forsgren
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

3.  Hereditary deficiency of the second component of complement (C'2) in man.

Authors:  M R Klemperer; H C Woodworth; F S Rosen; K F Austen
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

4.  Opsonic activity in human serum deficient in C2.

Authors:  F R Johnson; V Agnello; R C Williams
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.

Authors:  J K Phillips; R Snyderman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

6.  Dual pathways of complement interaction with guinea pig immunoglobulins.

Authors:  A L Sandberg; A G Osler
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

7.  Opsonic activity of agammaglobulinemic human sera.

Authors:  R C Williams; P G Quie
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

8.  Studies of an additional kindred with hereditary deficiency of the second component of human complement (C2) and description of a new method for the quantitation of C2.

Authors:  N R Cooper; R ten Bensel; P F Kohler
Journal:  J Immunol       Date:  1968-12       Impact factor: 5.422

9.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.

Authors:  S Ruddy; M R Klemperer; F S Rosen; K F Austen; J Kumate
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397
View more
  20 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Evidence for quantitative variability of bacterial opsonic requirements.

Authors:  J C Guckian; W D Christensen; D P Fine
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

5.  Opsonization of various capsular (K) E. coli by the alternative complement pathway.

Authors:  P Stevens; L S Young; S Adamu
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

6.  Comparative role of complement in pneumococcal and staphylococcal pneumonia.

Authors:  J D Coonrod; K Yoneda
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

8.  Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

10.  Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.

Authors:  P Leist-Welsh; A B Bjornson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.